News & Events

Press Releases

Salarius Pharmaceuticals Announces Two Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting

Salarius Pharmaceuticals to Present In Vitro Data on Seclidemstat in Small Cell Lung Cancer at the Keystone Symposia

Salarius Pharmaceuticals Receives $1.48 Million from the Cancer Prevention and Research Institute of Texas

Salarius Pharmaceuticals Presents SP-3164 Preclinical Data at the Inaugural Molecular Glue Drug Development Summit

Events

ASH ANNUAL MEETING & EXPOSITION

Dec 10 - Dec 13

H.C. Wainwright Global Investment Conference

May 24 - May 27

Q1 2022 Salarius Pharmaceuticals Earnings Webcast and Conference Call

May 12 @ 5:00pm EST

Listen to Webcast

Q4 2021 Salarius Pharmaceuticals Earnings Webcast and Conference Call

Mar 10 @ 5:00pm EST

Listen to Webcast

In the News

Global Newswire

Salarius Expands Oncology Pipeline Through Acquisition of Targeted Protein Degradation Portfolio from DeuteRx, LLC

The Clinical Trials Guru

David Arthur, Salarius CEO Speaks with Dan Sfera of The Clinical Trials Guru

Houston Business Journal

Salarius Pharmaceuticals raises millions for expanded clinical trial, moves office in TMC

15 Biotech Companies in Houston Making a Major Impact on Medicine

Empowered Patient Podcast

Targeting Epigenetic Causes of Ewing’s Sarcoma with David Arthur Salarius Pharmaceuticals on Empowered Patient Podcast with Karen Jagoda

Reportable News

Salarius During the JP Morgan Week – Attend the Biotech Showcase Presentation or Join the Live Webcast